Please Wait...

J. Michael O'Neal

Translation skills

Main profile

J. Michael O'Neal, M.D.
J. Michael O'Neal, M.D.
Chief Medical Officer

As the Chief Medical Officer at Bioclinica, Dr. O'Neal provides leadership to all on-staff radiologists and external radiology consultants, manages the organizational planning and operational needs of Bioclinica's Medical Affairs department, and oversees physician training, service quality, and process improvements.

Dr. O'Neal is a graduate of Rutgers University and earned his M.D. at the Universidad Autonoma de Guadalajara. He has over 20 years of experience with extensive clinical training in internal medicine and diagnostic radiology including an imaging fellowship at St. Barnabas Medical Center. In addition to oversight of imaging data in support of regulatory approval for many oncology drugs, Dr. O'Neal has participated in protocol review, charter development, and independent review for nearly 300 clinical trials to date.

Dr. O'Neal holds certifications from the American Board of Radiology and the American College of Radiology and is a member of many professional organizations, including the Radiological Society of North America (RSNA), the American College of Radiology (ACR), the American Medical Association (AMA), the Drug Information Association (DIA), the American Society for Clinical Oncology (ASCO), and the American Society of Hematology (ASH). Prior to joining Bioclinica, he served as the Chairman for the Department of Radiology at the Hospital Center at Orange, as the Vice President of Medical Affairs at RadPharm, and as the Chief Medical Officer at Core Lab Partners.

 

 
 
 
 

 

Authored Publications

Van Heertum RL, Scarimbolo R, Ford R, Berdougo E, O’Neal M. Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials. Drug Design, Development and Therapy 2015:9 5215–5223.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Think a #CTMS implementation takes too much time and too many resources? It doesn’t have to. Learn how a configurab… https://t.co/yowxvVTyP3
Bioclinica (2 days ago)
We think you should have access to the full suite of #ClinicalDataManagement services to ensure high-quality, relia… https://t.co/jVuliQwFo3
Bioclinica (2 weeks ago)
A mid-study change to a new #IRT vendor can be required for a number of reasons and can introduce a certain amount… https://t.co/sU7akWjdCD
Bioclinica (2 weeks ago)
A clinical trial rescue or transition presents a unique set of challenges for study teams. Join us on July 21 for a… https://t.co/rlYiFYpR6G
Bioclinica (3 weeks ago)
Rapid #CTMS implementation shouldn’t mean sacrificing features and functionality. With a modular approach, a full-f… https://t.co/gwqFtB8lhe
Bioclinica (4 weeks ago)
How prepared are you for a #clinicaltrial transition? With proper planning, the impact to sites and patients can be… https://t.co/vOqwC5vzzd
Bioclinica (5 weeks ago)